Protective Effects of Vildagliptin against Pioglitazone-Induced Bone Loss in Type 2 Diabetic Rats

Long-term use of thiazolidinediones (TZDs) is associated with bone loss and an increased risk of fracture in patients with type 2 diabetes (T2DM). Incretin-based drugs (glucagon-like peptide-1 (GLP-1) agonists and dipeptidylpeptidase-4 (DPP-4) inhibitors) have several benefits in many systems in add...

Descripción completa

Detalles Bibliográficos
Autores principales: Eom, Young Sil, Gwon, A-Ryeong, Kwak, Kyung Min, Kim, Ju-Young, Yu, Seung Hee, Lee, Sihoon, Kim, Yeun Sun, Park, Ie Byung, Kim, Kwang-Won, Lee, Kiyoung, Kim, Byung-Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5172620/
https://www.ncbi.nlm.nih.gov/pubmed/27997588
http://dx.doi.org/10.1371/journal.pone.0168569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5172620/
https://www.ncbi.nlm.nih.gov/pubmed/27997588
http://dx.doi.org/10.1371/journal.pone.0168569

Ejemplares similares